Abivax S.A. (ABVX)
NASDAQ: ABVX
· Real-Time Price · USD
95.89
0.26 (0.27%)
At close: Oct 14, 2025, 10:25 AM
Abivax S.A. Income Statement
Financials in EUR. Fiscal
year is
January - December.
| Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
Revenue | 10.79M | 4.62M | 4.58M | 37K |
Cost of Revenue | n/a | n/a | 110K | 156K |
Gross Profit | 10.79M | 4.57M | 4.47M | -119K |
Operating Income | -172.98M | -127.38M | -64.84M | -41.4M |
Interest Income | n/a | 2.77M | n/a | 84K |
Pretax Income | -176.24M | -152.23M | -74.32M | -42.45M |
Net Income | -176.24M | -147.74M | -60.74M | -42.45M |
Selling & General & Admin | 38.9M | 28.82M | 7.49M | 5.58M |
Research & Development | 146.53M | 103.18M | 48.73M | 47.78M |
Other Expenses | -1.66M | -47K | n/a | -11.96M |
Operating Expenses | 183.78M | 127.38M | 56.54M | 42.6M |
Interest Expense | n/a | 13.83M | 6.94M | 3.56M |
Selling & Marketing Expenses | 5.95M | 709K | n/a | n/a |
Cost & Expenses | 183.78M | 131.95M | 56.65M | 42.6M |
Income Tax Expense | n/a | -4.49M | -4.48M | n/a |
Shares Outstanding (Basic) | 63.05M | 43.07M | 19.09M | 15.46M |
Shares Outstanding (Diluted) | 63.05M | 43.07M | 19.09M | 15.46M |
EPS (Basic) | -2.8 | -3.43 | -3.18 | -2.75 |
EPS (Diluted) | -2.8 | -3.43 | -3.18 | -2.75 |
EBITDA | -171.88M | -133.21M | -53.31M | -38.59M |
EBIT | -172.98M | -133.91M | -53.8M | -38.89M |
Depreciation & Amortization | 1.1M | 707K | 485K | 156K |